GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Total Receivables

Trajan Group Holdings (ASX:TRJ) Total Receivables : A$19.6 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Total Receivables?

Trajan Group Holdings's Total Receivables for the quarter that ended in Dec. 2023 was A$19.6 Mil.


Trajan Group Holdings Total Receivables Historical Data

The historical data trend for Trajan Group Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Total Receivables Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23
Total Receivables
10.33 20.75 23.52

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Receivables Get a 7-Day Free Trial 15.77 20.75 19.65 23.52 19.63

Trajan Group Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Trajan Group Holdings Total Receivables Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Trajan Group Holdings (ASX:TRJ) Business Description

Traded in Other Exchanges
N/A
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.

Trajan Group Holdings (ASX:TRJ) Headlines

No Headlines